# Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients

> **NCT03640026** · PHASE4 · TERMINATED · sponsor: **Centre Hospitalier Departemental Vendee** · enrollment: 61 (actual)

## Conditions studied

- Kidney Failure, Chronic

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT03640026
- **Lead sponsor:** Centre Hospitalier Departemental Vendee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-08
- **Primary completion:** 2025-11-10
- **Final completion:** 2025-11-10
- **Target enrollment:** 61 (ACTUAL)
- **Why stopped:** Recruitment difficulties
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03640026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03640026, "Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03640026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*